 1. Чазова И.Е. Мартынюк Т.В., Авдеев С.Н., Арутюнов Г.П., Волков А.В., Наконечников С.Н., Привалова Е.В. Диагностикаилечениелегочной гипертензии. Российские рекомендации. «Кардиоваскулярная терапия и профилактика» 2007; №6.<br />
2.Чазова И. Е., Авдеев С. Н., Царева Н. А., Волков А. В., Мартынюк Т. В., Наконечников С.Н..Клинические рекомендации подиагностикеилечениюлегочной гипертонии. Терапевтический архив 2014; №9: с.4-23.<br />
3. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS).EurRespirJ. 2015; №46 (4):с.903-75.<br />
4. MM Hoeper, HJ Bogaard,R. Condliffe, et al. DefinitionsandDiagnosis of Pulmonary Hypertension. J Am Coll Cardiology 2013; Vol. 62, Suppl D: с.D42–50.<br />
5. Callahan W.E., Amorosino C.S. Endothelial dysfunction in pulmonary hypertension. N Engl J Med 1992; №327: с.177-119.<br />
6. Morrell N., Adnot S., Archer S. et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am CollCardiol 2009; №54 (Suppl. 1): с.S20–S31.<br />
7. Machado R, Eickelberg O, Elliott CG, et al. Genetics and genomics of pulmonary arterial hypertension. J Am CollCardiol 2009;№54:с.S32-S42.<br />
8. Heath D, Edwards JE. The pathology ofhypertensivepulmonary vascular disease. Circulation. 1958; №18: с.533-547.<br />
9.D"Alto M (http://www.ncbi.nlm.nih.gov/pubmed/? term=D%27Alto%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23204121),Mahadevan VS (http://www.ncbi.nlm.nih.gov/pubmed/? term=Mahadevan%20VS%5BAuthor%5D&cauthor=true&cauthor_uid=23204121). Pulmonary arterial hypertension associated with congenital heart disease.Eur Respir Rev. (http://www.ncbi.nlm.nih.gov/pubmed/? term=Eur+Respir+Rev+2012%3B+21%3A+126%2C+328%E2%80%93337)2012; №21(126):с.328-37.<br />
10. Gorbachevsky SV,ShmaltsAA, Zaets SB. What Can Cause Pulmonary Vascular Disease in Functionally Single Ventricle? Anatomy&Physiology 2016; №6(1):с.1000е137.<br />
11.Мартынюк Т.В. Идиопатическая легочная гипертензия:клиникопатофизиологические особенности и возможности патогенетически обоснованной терапии. Автореф. дисс. док мед. наук- М., 2013.<br />
12.JLVachi?ry, Y/ Adir, JABarber?, et al. Pulmonary Hypertension Due to Left Heart Diseases. J Am Coll Cardiology 2013; Vol. 62, Suppl D: с.D100–108.<br />
13. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J RespirCrit Care Med 2005;№172:с.189-194.<br />
14. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006;№113:с.2011-2020.<br />
15.Guidelines for the diagnosis and treatment of pulmonary hypertension. Update 2009. European society of cardiology. Eur Heart Journal 2009;№30:с.2493-2537.<br />
16. Hatano S, Strasser T. World Health Organization 1975. Primary pulmonary hypertension. Geneva: WHO; 1975.<br />
17. Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. EurRespirJ 2013;№41:с.217–223.<br />
18. Беленков Ю.Н., Чазова И.Е. Первичная легочная гипертензия. М: Нолидж 1991г.; с. 13-20.<br />
19. Rich JD, Thenappan T, Freed B, Patel AR, Thisted RA, Childers R, Archer SL. QTcprolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. Int J Cardiol 2013;№167:с.669–676.<br />
20. Milne EN. Forgotten gold in diagnosing pulmonary hypertension: the plain chest radiograph. Radiographics 2012;№32:с.1085–1087.<br />
21. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J RespCrit Care Med 2009;№179:с.615-621.<br />
22.MukerjeeD, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004;№43:с.461-466.<br />
23. Данилов Н.М., Мартынюк Т.В.,БеляткоЕ.А, др. Острые фармакологические пробы при легочной гипертензии: оценка эффективности ингаляционного илопроста. Consilium Medicum (кардиология) 2013; №15(10): с. 86-90.<br />
24. Мартынюк Т.В., С.Н.Наконечников, И.Е.Чазова.На пути оптимизации подходов клечениюхронической тромбоэмболической легочной гипертензии. СonsiliumMedicum. 2016;№ 5:с.53-58. (http://www.con-med.ru/magazines/consilium_medicum/230629/)<br />
25. (http://www.con-med.ru/magazines/consilium_medicum/230629/)Sun XG, Hansen JE, OudizRJ,Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003;№41:с.1028–1035.<br />
26. Tunariu N, Gibbs SJR, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;№48:с.680-684.<br />
27. Shen Y,Wan C, Tian P, et al. CT-base pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review. Medicine (Baltimore) 2014;№93:с.e256.<br />
28. Castaner E, Alguersuari A, Andreu M, et al. Imaging findings in pulmonary vasculitis. Semin Ultrasound CT MR 2012;№33:с.567–579.<br />
29. Oudiz RJ, Barst RJ, Hansen JE, et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006;№97:с.123-126.<br />
30. Ross RM. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;№167:с.1451.<br />
31. Легочная гипертензия. Под редакцией И.Е. Чазовой и Т.В. Мартынюк. Москва. Практика. 2015.<br />
32. Weitzenblum E, Sautegeau A, Ehrhart M, et al. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; №131:с.493-498.<br />
33. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;№327:с.76-81.<br />
34. Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;№111:с.3105-3111.<br />
35. Galie N, Manes A, Branzi A. Prostanoids for pulmonary arterial hypertension. Am J RespirMed 2003;№2:с.123-137.<br />
36. McLaughlin VV, Oudiz RJ, Frost A. et al. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension Am J RespirCrit Care Med 2006; №174:с.1257-1263.<br />
37. Антагонисты рецепторов эндотелина. Чазова И.Е., Мартынюк Т.В. Глава в руководстве «Рациональная фармакотерапия сердечнососудистых заболеваний» под редакцией Е.И.Чазова, Ю.А.Карпова. Москва, 2014:с.281-290.<br />
38. Мартынюк Т.В., Архипова О.А., Кобаль Е.А.,др. Применение неселективного антагониста рецепторов эндотелинабозентана у больных идиопатической легочной гипертензией: первый российский опыт и взгляд в будущее. Системныегипертензии 2011, № 4, с.51-57.<br />
39. TaichmanD.B., OrnelasJ., ChungL. etal.Pharmacologic therapy for Pulmonary Arterial Hypertension in Adults CHEST Guideline and Expert Panel Report. CHEST 2014; №146 (2): с.449 - 475.<br />
40. Авдеев С.Н. Новый антагонист рецепторов эндотелинамацитентан:перспективы терапии легочной артериальной гипертензии. Тер архив 2016 № 7:с.89-98.<br />
41. Мартынюк Т.В., Чазова И.Е.. Роль силденафила в лечении больных легочной артериальной гипертензией. Системные гипертензии 2012; №2:с.23-29.<br />
42. Ингибиторы фосфодиэстеразы типа 5. Глава в руководстве «Рациональная фармакотерапия сердечно-сосудистых заболеваний» под редакцией Е.И.Чазова, Ю.А.Карпова. Москва, 2014: с.273-281.<br />
43.Ghofrani H-A, et al. Riociguat for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med 2013;№369:с.330-40.<br />
44. Hoeper MM, Corris PA, Kinger JR, et al. The RESPITE Study: Riociguat In Patients With PAH And An Inadequate Response To Phosphodiesterase 5 Inhibitors. Am J Crit Care Med 2016; №193: A6315.<br />
45. Sandoval J, Gaspar J, Pulido T, Bautista E, Mart??nez Guerra ML, Zeballos M, Palomar A, Go?mez A. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am CollCardiol 1998;№32:с.297304.<br />
46. Kurzyna M, Dabrowski M, Bielecki D, et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest 2007;№131:с.977-983.<br />
47. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;№25:.с.745-755.<br />
48. Trulock EP, Edwards LB, Taylor DO, et al. International Society for Heart and Lung Transplantation. Registry of the International Society for Heart and Lung Transplantation: twenty third official adult lung and heart lung transplantation report - 2006. J Heart Lung Transplant 2006;№25:с.880-892.<br />
49. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006;№114:с.1482-1489.<br />
50.The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. EurHeartJ 2003;№24:с.761-781.<br />
51. Galie N, Palazzini M, Manes A. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur Heart J 2010; №31: с.2080-2086.<br />
52. Jais X, Olsson KM, Barbera JA, et al. Pregnansy outcomes in pulmonary arterial hypertension in the modern management era. EurRespir J 2012;№40:с.881-885.<br />
53. Duarte AG, Thomas S, Safdar Z, et al. Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience.Chest2013;№143:с.1330-1336.<br />
54. Meyer S, McLaughlin VV, Seyfarth HJ, et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. EurRespir J 2013;№41:с.1302-1307.<br />
55. Thorne S, Nelson-Piercy C, MacGregor AJ, et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam PlannReprod Health Care 2006;№32:с.75-81.<br />
56. Dinh-Xuan AT, Higenbottam T, Clelland C, et al. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive pulmonary disease. N Engl J Med 1991; №324: с.1539- 1547.<br />
57. Zieche R, Petkov V, Williams J. et al. Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in chronic obstructive pulmonary disease. Proc Natl AcadSci USA 1996;№ 93: с.12478- 83<br />
58. Scherptong RW,Henkens IR, Kapel GF et al. Diagnosis and mortality prediction in pulmonary hypertension: the value of the electrocardiogramderived ventricular gradient. J Electrocardiol. 2012;№45(3):с.312-8.<br />
59. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; №127: с.1531-4.<br />
60. Nathan S, Shlobin O, Ahmad S, et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; №131: с.657–663.<br />
61. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Committee for Practice Guidelines. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32(24): c.3147-397.<br />
62. Olsson KM, Channick R. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev. 2016; 25: с.431-437.<br />
63. HemnesAR,KielyDG,CockrillBA,et al.Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.Pulm Circ2015;5:c.435–465.<br />
64. Mantha S, Karp R, Raghavan V, et al. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012; 345: e4944.<br />
65. Olsson KM, Jais X. Birth control and pregnancy management in pulmonary hypertension. Semin Respir Crit Care Med 2013; 34:с.681–688.<br />
66. Duarte AG, Thomas S, Safdar Z, et al. Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience.Chest2013;№143: с.1330-1336.<br />
67. B?dardE,DimopoulosK,GatzoulisMA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?Eur Heart J2009;30:с.256–265<br />
68. Hsu CH, Gomberg-Maitland M, Glassner C, et al. The management of pregnancy and pregnancy-related medical conditions in pulmonary arterial hypertension patients. Int J Clin Pract Suppl 2011; 175: с.6–14.<br />
69. Sulica R, Preston IElwing JM, Panos RJ. Pregnancy and pulmonary arterial hypertension. In: Sulica R, Preston I, eds. Pulmonary hypertension-from bench research to clinical challenges. Rijeka, InTech, 2011.<br />
70. TreinenKA,LoudenC,DennisMJ,et a Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits.Teratology1999;59:с.51–59.<br />
71. Баутин А.Е., Якубов А.В., Коконина Ю.А., Ильин А.Б., Ли О.А., Иртюга О.Б., Мазурок В.А,, Зазерская И.Е. Моисеева О.М. Анестезиологическое обеспечение и интенсивная терапия в периоперационном периоде абдоминального родоразрешения у беременных с легочной артериальной гипертензией.Анестезиология и реаниматология2016; №6. Принята в печать<br />
72. Bonnin M, Mercier FJ, Sitbon O, et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102: с.1133–1137.<br />
73. Terek D, Kayikcioglu M, Kultursay H, et al. Pulmonary arterial hypertension and pregnancy. J Res Med Sci 2013; 18: с.73–76.<br />
74. Madden BP. Pulmonary hypertension and pregnancy. Int J Obstet Anesth 2009; 18: 156–164.<br />
75. Uebing A, Steer PJ, Yentis SM, et al. Pregnancy and congenital heart disease. BMJ 2006; 332:с. 401–406. 

 76. Weiss BM, Maggiorini M, Jenni R, et al. Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology 2000; 92: с.1191–1194.<br />
77. Yamaguchi ET, Cardoso MM, Torres ML. Oxytocin in cesarean sections: what is the best way to use it? Rev Bras Anestesiol 2007; 57: с.324–350.<br />
78. Albackr HB, Aldakhil LO, Ahamd A. Primary pulmonary hypertension during pregnancy: a case report. J Saudi Heart Assoc 2013; 25: с.219–223. 